» Articles » PMID: 32705280

Retinoic Acid Induces Differentiation in Neuroblastoma Via ROR1 by Modulating Retinoic Acid Response Elements

Overview
Journal Oncol Rep
Specialty Oncology
Date 2020 Jul 25
PMID 32705280
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Neuroblastoma is the most common inheritable, solid neoplasm in children found under the age of 7 and accounts for approximately 7% of childhood cancers. A common treatment that has been prescribed for over a decade is retinoid therapy [using all‑trans retinoic acid (RA)]. Treatment with this differentiating agent has been revealed to progress the cells from their stem‑cell state to a mature neuronal state gaining classical neuronal characteristics, including the suppression of proliferation. However, the molecular mechanism underlying the action of RA treatment remains to be elucidated. In the present study, a novel mechanism of RA‑induced differentiation via regulation of receptor tyrosine kinase‑like orphan receptor 1 (ROR1) is reported. ROR1 is overexpressed in neuroblastoma but significantly downregulated in mature differentiated neurons. Hence, it was hypothesized that RA may modulate ROR1 leading to differentiation and termination of cancerous properties. Immunoblotting revealed that following RA treatment, ROR1 levels initially increased then sharply decreased by 96 h. This was paired with synaptophysin, a mature neuron marker, sharply increasing concurrently, providing evidence of differentiation by 96 h. Investigation of the ROR1 pathway confirmed ROR1‑dependent downstream activation of the PI3K/AKT signaling axis, a growth pathway previously demonstrated to promote differentiation. Chromatin immunoprecipitation revealed an increase in RAR binding to the promoters of ROR1 and its endogenous ligand, Wnt5a. This research provided compelling evidence that RA is able to modulate the expression of ROR1 and Wnt5a to promote differentiation through the expression of synaptophysin. This data combined with the overarching data from the scientific community regarding proliferation and other proliferative factors in early‑stage neurons provides a more in‑depth model of the process of differentiation in neurons.

Citing Articles

Neuropathiazol induces neuronal-like differentiation in neuroblastoma cells via upregulation of PEG5.

Xu H, Zhang F, Xu Y, Chen T, Yuan F, Nie Q Pediatr Res. 2025; .

PMID: 39972157 DOI: 10.1038/s41390-025-03925-1.


Antioxidant, neuroprotective, and neuroblastoma cells (SH-SY5Y) differentiation effects of melanins and arginine-modified melanins from Daedaleopsis tricolor and Fomes fomentarius.

Nguyen H, Ho T, Mangelings D, Van Eeckhaut A, Vander Heyden Y, Tran H BMC Biotechnol. 2024; 24(1):89.

PMID: 39529092 PMC: 11556217. DOI: 10.1186/s12896-024-00918-6.


Pulse Activation of Retinoic Acid Receptor Enhances Hematopoietic Stem Cell Homing by Controlling CXCR4 Membrane Presentation.

Geng N, Yu Z, Zeng X, Chen Y, Sheng M, Xu D Stem Cell Rev Rep. 2024; 21(1):68-79.

PMID: 39480614 DOI: 10.1007/s12015-024-10813-4.


Effects of Anionic Liposome Delivery of All--Retinoic Acid on Neuroblastoma Cell Differentiation.

Mino A, Lopez F, Barbaro R, Barile M, Ambrosone L, Colella M Biomimetics (Basel). 2024; 9(5).

PMID: 38786467 PMC: 11118614. DOI: 10.3390/biomimetics9050257.


Biological Implications and Functional Significance of Transglutaminase Type 2 in Nervous System Tumors.

Buccarelli M, Castellani G, Fiorentino V, Pizzimenti C, Beninati S, Ricci-Vitiani L Cells. 2024; 13(8.

PMID: 38667282 PMC: 11048792. DOI: 10.3390/cells13080667.


References
1.
Habib E, El-Kashef A, Fahmy E . Management of neuroblastoma: a study of first- and second-line chemotherapy responses, a single institution experience. Oncol Rev. 2015; 6(1):e3. PMC: 4419637. DOI: 10.4081/oncol.2012.e3. View

2.
Bown N . Neuroblastoma tumour genetics: clinical and biological aspects. J Clin Pathol. 2001; 54(12):897-910. PMC: 1731335. DOI: 10.1136/jcp.54.12.897. View

3.
Kam R, Deng Y, Chen Y, Zhao H . Retinoic acid synthesis and functions in early embryonic development. Cell Biosci. 2012; 2(1):11. PMC: 3325842. DOI: 10.1186/2045-3701-2-11. View

4.
Louis C, Shohet J . Neuroblastoma: molecular pathogenesis and therapy. Annu Rev Med. 2014; 66:49-63. PMC: 4418018. DOI: 10.1146/annurev-med-011514-023121. View

5.
Qiao J, Paul P, Lee S, Qiao L, Josifi E, Tiao J . PI3K/AKT and ERK regulate retinoic acid-induced neuroblastoma cellular differentiation. Biochem Biophys Res Commun. 2012; 424(3):421-6. PMC: 3668681. DOI: 10.1016/j.bbrc.2012.06.125. View